Clinical Trial Update: Signature for Precise Chemosensitivity Prediction in PDAC

View source ↗

Summary

A clinical trial evaluating a signature for precise chemosensitivity prediction in pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Ruijin Hospital | Conditions: Pancreatic Cancer | Status: COMPLETED